Clifford Chance advised Charme Capital Partners on the deal. Charme Capital Partners, a pan-European private equity firm, announced the acquisition of Centogene GmbH, a rare diseases...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Amundi on the deal. Amundi Asset Management SAS finalized its €149 million strategic acquisition of aixigo AG, a technology company that has developed...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised UPS on the deal. UPS acquired Frigo-Trans GmbH and its sister company BPL, industry-leading, complex healthcare logistics providers based in Germany. With...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Onex Corporation on the deal. Onex Corporation (TSX: ONEX) announced that Onex Partners Opportunities Fund has agreed to make a majority investment in...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised HID on the deal. HID, a worldwide leader in trusted identity solutions, has acquired Sewio Networks (Sewio), a leading provider of Ultra-Wideband (UWB)...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised MiddleGround Capital on investment agreement with STEMMER IMAGING AG and intended voluntary public takeover offer. US private equity firm MiddleGround Capital signed an...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Hitachi Ltd. on the deal. Hitachi Ltd. has signed a stock purchase agreement to acquire all shares of MA micro automation GmbH from...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised International Chemical Investors Group (ICIG). International Chemical Investors Group (ICIG) took over the entire division with around 1,000 employees and superabsorber production facilities in...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Paragon Partners on the investment. Paragon invests in the Primed Group, a leading provider of medical consumables and sterilization services based in Halberstadt,...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised RHI Magnesita on the acquisition. RHI Magnesita completed the acquisition of the entire Preiss-Daimler Group refractory business (P-D Refractories) with sites in Germany, the...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Minoryx Therapeutics on the deal. Clifford Chance advised the Neuraxpharm Group. Minoryx Therapeutics, a late-stage biotech company focused on the development of treatments...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised investment manager ehret+klein Capital Markets on the deal. ehret+klein Capital Markets acquired the listed former hotel building “The Loom” on Warschauer Platz in...
You must be a Standard 1 Year member to access this content.
